Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Johnson and Johnson
Argus Health
Julphar
AstraZeneca
Cipla
Moodys
US Army
Boehringer Ingelheim

Generated: December 17, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NALOXONE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Naloxone Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00000192 Neurobiology of Opioid Dependence: 1 - 1 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate the effects of lamotrigine on naloxone-precipitated opiate withdrawal.
NCT00000192 Neurobiology of Opioid Dependence: 1 - 1 Withdrawn Yale University Phase 2 The purpose of this study is to evaluate the effects of lamotrigine on naloxone-precipitated opiate withdrawal.
NCT00000193 Neurobiology of Opioid Dependence: 2 - 2 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.
NCT00000193 Neurobiology of Opioid Dependence: 2 - 2 Withdrawn Yale University Phase 2 The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.
NCT00000194 Neurobiology of Opioid Dependence: 3 - 3 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to study the effects of cycloserine on naloxone-precipitated opiate withdrawal.
NCT00000194 Neurobiology of Opioid Dependence: 3 - 3 Withdrawn Yale University Phase 2 The purpose of this study is to study the effects of cycloserine on naloxone-precipitated opiate withdrawal.
NCT00000243 Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone Terminated National Institute on Drug Abuse (NIDA) N/A Buprenorphine is a drug that may be helpful in treating opioid dependent individuals who were previously maintained on methadone. The purpose of this study is to determine the effects of different doses of buprenorphine/naloxone in treating opioid dependent individuals who were previously maintained on methadone.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Naloxone Hydrochloride

Condition Name

Condition Name for Naloxone Hydrochloride
Intervention Trials
Opioid-Related Disorders 36
Pain 23
Opioid Dependence 16
Heroin Dependence 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Naloxone Hydrochloride
Intervention Trials
Opioid-Related Disorders 58
Constipation 17
Heroin Dependence 15
Substance-Related Disorders 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Naloxone Hydrochloride

Trials by Country

Trials by Country for Naloxone Hydrochloride
Location Trials
United States 349
China 21
Norway 13
Canada 13
Germany 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Naloxone Hydrochloride
Location Trials
New York 34
California 25
Maryland 23
Connecticut 15
Florida 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Naloxone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Naloxone Hydrochloride
Clinical Trial Phase Trials
Phase 4 55
Phase 3 46
Phase 2/Phase 3 7
[disabled in preview] 136
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Naloxone Hydrochloride
Clinical Trial Phase Trials
Completed 139
Recruiting 36
Not yet recruiting 23
[disabled in preview] 46
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Naloxone Hydrochloride

Sponsor Name

Sponsor Name for Naloxone Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 48
Mundipharma Research GmbH & Co KG 12
Indivior Inc. 12
[disabled in preview] 27
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Naloxone Hydrochloride
Sponsor Trials
Other 203
Industry 91
NIH 57
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
US Department of Justice
Queensland Health
US Army
AstraZeneca
Mallinckrodt
Cipla
Cantor Fitzgerald
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.